Type 2 Diabetes Trial, Recruiting NCT06752772 Sponsor: Alexandra Hospital Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06752772
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People between 21 and 75 years old
  • People who are at risk of high blood pressure, being overweight (BMI of 23 or above), or pre-diabetes
  • People who have been diagnosed with one or more of the following: high blood pressure, obesity (BMI of 27.5 or above), high cholesterol, or Type 2 Diabetes
  • People who own a smartphone
  • People who are willing to wear a smartwatch throughout the study period

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a medical condition that stops them from taking part in physical activity
  • People who currently have, or have a history of, an eating disorder or depression
  • People who are currently pregnant or planning to become pregnant within the next 6 months
  • People who are currently taking part in any weight loss program, whether commercial, medically supervised, or a research study
  • People who are currently taking any weight loss medications, whether bought over the counter or prescribed by a doctor
  • People who are not able to participate mentally, physically, or with the use of technology
  • People who are unable to give informed consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 96505306

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Alexandra Hospital
Registry
ClinicalTrials.gov
Start date
6 August 2024
Est. completion
1 November 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Changes in physical activity level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov